BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 12409337)

  • 1. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.
    Dvorak HF
    J Clin Oncol; 2002 Nov; 20(21):4368-80. PubMed ID: 12409337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
    Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
    EXS; 1997; 79():233-69. PubMed ID: 9002222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.
    Basu S; Nagy JA; Pal S; Vasile E; Eckelhoefer IA; Bliss VS; Manseau EJ; Dasgupta PS; Dvorak HF; Mukhopadhyay D
    Nat Med; 2001 May; 7(5):569-74. PubMed ID: 11329058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.
    Pal S; Iruela-Arispe ML; Harvey VS; Zeng H; Nagy JA; Dvorak HF; Mukhopadhyay D
    Microvasc Res; 2000 Sep; 60(2):112-20. PubMed ID: 10964585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
    Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
    Senger DR; Ledbetter SR; Claffey KP; Papadopoulos-Sergiou A; Peruzzi CA; Detmar M
    Am J Pathol; 1996 Jul; 149(1):293-305. PubMed ID: 8686754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular permeability factor, tumor angiogenesis and stroma generation.
    Senger DR; Brown LF; Claffey KP; Dvorak HF
    Invasion Metastasis; 1994-1995; 14(1-6):385-94. PubMed ID: 7544775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
    Watanabe Y; Lee SW; Detmar M; Ajioka I; Dvorak HF
    Oncogene; 1997 May; 14(17):2025-32. PubMed ID: 9160882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability.
    Eriksson A; Cao R; Roy J; Tritsaris K; Wahlestedt C; Dissing S; Thyberg J; Cao Y
    Circulation; 2003 Mar; 107(11):1532-8. PubMed ID: 12654612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.
    Dvorak HF; Detmar M; Claffey KP; Nagy JA; van de Water L; Senger DR
    Int Arch Allergy Immunol; 1995; 107(1-3):233-5. PubMed ID: 7542074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of vascular endothelial growth factor/ vascular permeability factor in periapical lesions.
    Leonardi R; Caltabiano M; Pagano M; Pezzuto V; Loreto C; Palestro G
    J Endod; 2003 Mar; 29(3):180-3. PubMed ID: 12669876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.
    Schuch G; Machluf M; Bartsch G; Nomi M; Richard H; Atala A; Soker S
    Blood; 2002 Dec; 100(13):4622-8. PubMed ID: 12453880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
    Dvorak HF; Brown LF; Detmar M; Dvorak AM
    Am J Pathol; 1995 May; 146(5):1029-39. PubMed ID: 7538264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability.
    Kondo S; Matsumoto T; Yokoyama Y; Ohmori I; Suzuki H
    Biochim Biophys Acta; 1995 Feb; 1243(2):195-202. PubMed ID: 7533000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.